GeneLink, Inc. (GNLKQ)
GeneLink, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Orlando, FL, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $10,601. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -142.9%. Its beta of -0.13 implies it has historically moved less than the broad market.
GeneLink, Inc. specializes in delivering 12-gene DNA profiling services. Beyond genetic analyses, the company also provides clients with bespoke nutritional supplements tailored to individual health needs. Additionally, the firm crafts a comprehensive collection of dermatological products. Established in 1994, GeneLink, Inc. maintains its headquarters in Orlando, Florida.
GeneLink, Inc. is most often compared with the following Healthcare names: